Established on April 11, 2008, this Manufacturer is a wholly owned subsidiary of a global pharmaceutical supplier. As a CTD dossier owner and manufacturer, it specializes in introducing first-to-market pharmaceutical compounds, unique therapeutically optimized combinations, and value-branded equivalents. With a team of approximately 25 employees as of 2022, the Manufacturer operates in the Philippines, offering a diverse product portfolio. As a GMP manufacturer, it ensures compliance with stringent quality standards across all operations. Committed to excellence, this CTD dossier owner and manufacturer continues to expand its presence in regulated markets.